Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Conclusions: Although the current study did not demonstrate an improvement in PFS with the addition of IFRT to HDCT and HPCT, there was a trend toward improved overall survival. The potential benefit of IFRT may be underestimated because of the heterogeneity of the treatment groups. The use of IFRT was not associated with an increase in the risk of acute mortality or late events

Related Articles

Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma
Leukemia and Lymphoma, 11/04/09    Relevance Score: 87%%

Effects of Pulsed Electromagnetic Fields on IL-1beta and Post Operative Pain: A Double-Blind, Placebo-Controlled Pilot Study in Breast Reduction Patients
Plastic and Reconstructive Surgery, 11/23/09    Relevance Score: 79%%

Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer
European Journal of Cardio-Thoracic Surgery, 12/01/09    Relevance Score: 78%%

Juvenile xanthogranuloma masquerading as melanoma
Journal of American Association for Pediatric Ophthalmology and Strabismus, 11/04/09    Relevance Score: 78%%

Hormone Therapy Can Help Some with Prostate Cancer
MedLinePlus, 11/04/09    Relevance Score: 69%%

Today in Pharmacology/Therapy...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer
Expert Review of Anticancer Therapy, 12/04/09

Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address